Your browser doesn't support javascript.
loading
Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection.
Labonde, Amélie; Lades, Guillaume; Debourdeau, Antoine; Ragi, Olivier; Lehmann, Lauriane; Vitton, Véronique; Barthet, Marc; Legros, Romain; Albouys, Jérémie; Geyl, Sophie; Loustaud-Ratti, Véronique; Monteil, Jacques; Gonzalez, Sandra; Gonzalez, Jean-Michel; Jacques, Jérémie.
Afiliação
  • Labonde A; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
  • Lades G; Service de médecine nucléaire, CHU Limoges, Limoges, France.
  • Debourdeau A; Service d'Hépato-gastro-entérologie, CHU Montpellier, Montpellier, France.
  • Ragi O; Service d'Hépato-gastro-entérologie, CHU Lyon, Lyon, France.
  • Lehmann L; Service d'Hépato-gastro-entérologie, Polyclinique de Limoges, Limoges, France.
  • Vitton V; Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France.
  • Barthet M; Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France.
  • Legros R; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
  • Albouys J; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
  • Geyl S; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
  • Loustaud-Ratti V; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
  • Monteil J; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
  • Gonzalez S; Service de médecine nucléaire, APHM Hôpital Nord, Marseille, France.
  • Gonzalez JM; Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France.
  • Jacques J; Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France. Electronic address: jeremie.jacques@chu-limoges.fr.
Gastrointest Endosc ; 96(3): 500-508.e2, 2022 09.
Article em En | MEDLINE | ID: mdl-35413333
BACKGROUND AND AIMS: Limited data exist concerning the long-term efficiency of gastric peroral endoscopic myotomy (G-POEM) as a treatment of refractory gastroparesis. This study evaluated the 3-year results of G-POEM in patients with refractory gastroparesis. METHODS: This was a prospective multicenter study of all G-POEM operations performed in 2 expert French centers for 46 patients with refractory gastroparesis with at least 3 years of follow-up. RESULTS: Clinical success was 65.2% at 36 months. There was significant improvement in symptom severity. Median Gastroparesis Cardinal Symptom Index decreased from 3.33 to 1.80 (P < .0001), with improvement in all subscales. We created a predictive score concerning G-POEM success (G-POEM predictive score) to which points were assigned as follows: nausea subscale <2: predictive of success, 1 point; satiety subscale >4: predictive of success, 1 point; bloating subscale >3.5: predictive of success, 1 point; percentage of gastric retention at 4 hours on scintigraphy >50%: 1 point. A threshold of 2 was identified by receiver operating characteristic curve analysis with an area under the curve of .825 that predicted clinical success with a sensitivity of 93.3% (95% confidence interval [CI], .77-.99), specificity of 56.3% (95% CI, .33-.77), positive predictive value of 80% (95% CI, .67-.93), negative predictive value of 81.8% (95% CI, .59-1.00), and accuracy of 80.4% (95% CI, .69-.92). Patients with a score ≥2 were significantly more likely to be responders at 3 years than were patients with a score <2 (80% and 18%, respectively; P = .0004). CONCLUSIONS: The clinical success of G-POEM for refractory gastroparesis was 65.2% at 36 months. Our predictive score offers an easy tool that needs to be confirmed in other studies.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article